Dr Reddy's unveils osteoporosis drug

Dr Reddy
Highlights

Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating...

Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market. Osteoporosis is a disease of bones that leads to an increased risk of fracture while Paget's disease of bone is a chronic disorder that can result in enlarged and misshapen bones.

The company has launched Zoledronic Acid injection (5 mg/ 100 mL) on Wednesday following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), the company said in a release.

The injection is generic version of Novartis AG's Reclast injection in the same strength, it added. The Reclast brand had total US sales of approximately $355 million for the most recent twelve months ending February, 2013 according to IMS Health.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top